Evidence map›Paper›PMID 40175356›Full record

ArticleNature communications2025

The impact of a high fat diet and platelet activation on pre-metastatic niche formation.

Marta Hergueta-Redondo, Sara Sánchez-Redondo, Begoña Hurtado, Vanesa Santos, Manuel Pérez-Martínez, Pilar Ximénez-Embún, Sheri A C McDowell, Marina S Mazariegos, Gadea Mata, Raúl Torres-Ruiz and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Marta Hergueta-RedondoMicroenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Sara Sánchez-RedondoMicroenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Begoña HurtadoCancer Cell Cycle Group, Preclinical & Translational Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.ORCID http://orcid.org/0000-0002-8232-3238
Vanesa SantosMicroenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Manuel Pérez-MartínezConfocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0001-8839-6895
Pilar Ximénez-EmbúnProteomics Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Sheri A C McDowellRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Marina S MazariegosMicroenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Gadea MataConfocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-5567-8463
Raúl Torres-RuizMolecular Cytogenetics Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0001-9606-0398
Sandra Rodríguez-PeralesMolecular Cytogenetics Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0001-7221-3636
Lola MartínezFlow Cytometry Core Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Osvaldo Graña-CastroBioinformatics Unit, Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0003-1615-4242
Diego MegiasConfocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Daniela QuailRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0002-6969-3250
Miguel Quintela-FandinoBreast Cancer Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.ORCID http://orcid.org/0000-0003-1648-1964
Héctor PeinadoMicroenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain. hpeinado@cnio.es.ORCID http://orcid.org/0000-0002-4256-3413

Funding

"la Caixa" Foundation (Caixa Foundation) HR18-00256Worldwide Cancer Research 24-0197, 16-1244
6 · The paper itself

Abstract

There is active crosstalk between tumor cells and the tumor microenvironment during metastatic progression, a process that is significantly affected by obesity, particularly in breast cancer. Here we analyze the impact of a high fat diet (HFD) on metastasis, focusing on the role of platelets in the formation of premetastatic niches (PMNs). We find that a HFD provokes pre-activation of platelets and endothelial cells, promoting the formation of PMNs in the lung. These niches are characterized by increased vascular leakiness, platelet activation and overexpression of fibronectin in both platelets and endothelial cells. A HFD promotes interactions between platelets, tumor cells and endothelial cells within PMNs, enhancing tumor cell homing and metastasis. Importantly, therapeutic interventions like anti-platelet antibody administration or a dietary switch reduce metastatic cell homing and outgrowth. Moreover, blocking fibronectin reduces the interaction of tumor cells with endothelial cells. Importantly, when coagulation parameters prior to neoadjuvant treatment are considered, triple negative breast cancer (TNBC) female patients with reduced Partial Thromboplastin time (aPTT) had a significantly shorter time to relapse. These findings highlight how diet and platelet activation in pre-metastatic niches affect tumor cell homing and metastasis, suggesting potential therapeutic interventions and prognostic markers for TNBC patients.

Indexed as

Diet, High-FatLung NeoplasmsPlatelet ActivationTriple Negative Breast NeoplasmsTumor MicroenvironmentAnimalsBlood PlateletsCell Line, TumorEndothelial CellsFemaleFibronectinsHumansMiceNeoplasm MetastasisFibronectins

Identifiers

PMID40175356
PMCPMC11965330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.